Analyst Activity – Robert W. Baird Reiterates Hold on Celgene Corporation (NASDAQ:CELG)

ME Staff
-
0

Analyst Ratings For Celgene Corporation (NASDAQ:CELG)

Today, Robert W. Baird reiterated its Hold rating on Celgene Corporation (NASDAQ:CELG) with a price target of $103.00.

There are 2 sell ratings, 7 hold ratings, 20 buy ratings on the stock.

The current consensus rating on Celgene Corporation (NASDAQ:CELG) is Buy (Score: 2.62) with a consensus target price of $150.23 per share, a potential 50.24% upside.

Some recent analyst ratings include

  • 10/27/2017-Robert W. Baird Reiterated Rating of Hold.
  • 10/26/2017-Cann Reiterated Rating of Buy.
  • 10/26/2017-Wells Fargo & Company was Downgraded by analysts at Wells Fargo & Company from a “Outperform ” rating to a ” Market Perform” rating.
  • 10/23/2017-Guggenheim initiated coverage with a Buy rating.
  • 10/23/2017-Piper Jaffray Companies Reiterated Rating of Neutral .

Recent Insider Trading Activity For Celgene Corporation (NASDAQ:CELG)
Celgene Corporation (NASDAQ:CELG) has insider ownership of 0.95% and institutional ownership of 79.23%.

  • On 9/25/2017 Terrie Curran, Insider, sold 1,727 with an average share price of $143.89 per share and the total transaction amounting to $248,498.03. View SEC Filing
  • On 9/12/2017 Gilla Kaplan, Director, sold 9,250 with an average share price of $141.56 per share and the total transaction amounting to $1,309,430.00. View SEC Filing
  • On 9/5/2017 Michael D Casey, Director, sold 9,250 with an average share price of $139.03 per share and the total transaction amounting to $1,286,027.50. View SEC Filing
  • On 8/10/2017 Ernest Mario, Director, sold 18,506 with an average share price of $130.52 per share and the total transaction amounting to $2,415,403.12. View SEC Filing
  • On 8/2/2017 Gilla Kaplan, Director, sold 7,500 with an average share price of $134.52 per share and the total transaction amounting to $1,008,900.00. View SEC Filing
  • On 6/26/2017 James J Loughlin, Director, sold 18,500 with an average share price of $133.57 per share and the total transaction amounting to $2,471,045.00. View SEC Filing
  • On 6/22/2017 Michael A Friedman, Director, sold 10,000 with an average share price of $132.50 per share and the total transaction amounting to $1,325,000.00. View SEC Filing

Recent Trading Activity for Celgene Corporation (NASDAQ:CELG)
Shares of Celgene Corporation closed the previous trading session at with shares trading hands.